Trevi Therapeutics
TRVI
#4834
Rank
S$2.48 B
Marketcap
S$17.45
Share price
-1.31%
Change (1 day)
21.06%
Change (1 year)

EPS for Trevi Therapeutics (TRVI)

EPS in 2026 (TTM): S-$0.44

According to Trevi Therapeutics's latest financial reports the company's current EPS (TTM) is S-$0.44. In 2025 the company made an earnings per share (EPS) of S-$0.41 an increase over its 2024 EPS that were of S-$0.61.

EPS history for Trevi Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.446.23%
2025S-$0.41-31.91%
2024S-$0.61
2022S-$0.72
2020S-$2.3418.17%
2019S-$1.98